Drug Shortage Report for ACT PROGESTERONE INJECTION
Report ID | 97147 |
Drug Identification Number | 02446820 |
Brand name | ACT PROGESTERONE INJECTION |
Common or Proper name | PROGESTERONE 500MG/10ML INJ |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PROGESTERONE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-23 |
Estimated end date | 2020-05-31 |
Actual end date | 2020-05-08 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-24 | English | Compare |
v2 | 2019-10-24 | French | Compare |
v3 | 2020-03-05 | English | Compare |
v4 | 2020-03-05 | French | Compare |
v5 | 2020-04-23 | English | Compare |
v6 | 2020-04-23 | French | Compare |
v7 | 2020-05-14 | English | Compare |
v8 | 2020-05-14 | French | Compare |
Showing 1 to 8 of 8